sepsis - Nursing Case Study
Pathophysiology
• Primary mechanism: Dysregulated Host Response - Sepsis begins with the immune system's response to an infection, where the body's defense mechanisms become hyperactive, leading to widespread inflammation and tissue damage instead of targeting the infection.
• Secondary mechanism: Endothelial Dysfunction - The excessive inflammatory response causes the endothelial cells lining blood vessels to become permeable, resulting in fluid leakage, edema, and impaired blood flow, which can lead to organ dysfunction.
• Key complication: Multi-Organ Failure - The combination of inflammation and impaired perfusion can lead to the failure of multiple organ systems, such as the kidneys, liver, and heart, ultimately increasing morbidity and potentially leading to death if not promptly managed.
Patient Profile
Demographics:
65-year-old male, retired teacher
History:
• Key past medical history: Hypertension, Type 2 Diabetes, Chronic Kidney Disease Stage 3
• Current medications: Lisinopril, Metformin, Insulin, Amlodipine
• Allergies: Penicillin
Current Presentation:
• Chief complaint: Fever and confusion
• Key symptoms: High fever, tachycardia, altered mental status, oliguria
• Vital signs: Temperature 102.5°F, Heart rate 115 bpm, Respiratory rate 24 breaths/min, Blood pressure 92/58 mmHg, Oxygen saturation 93% on room air
Section 1
As the clinical team conducts an initial assessment, further details emerge that underscore the severity of the patient's condition. The 65-year-old male exhibits signs of worsening respiratory distress; his oxygen saturation has now decreased to 88% despite supplemental oxygen. Auscultation reveals diminished breath sounds in the lower lung fields, suggesting possible pulmonary edema or the development of acute respiratory distress syndrome (ARDS). His skin appears cool and clammy, with delayed capillary refill, indicating poor peripheral perfusion. The patient's level of consciousness continues to decline, as he is now only responsive to painful stimuli, highlighting the need for immediate intervention.
Laboratory results return, showing marked leukocytosis with a white blood cell count of 18,000/mm³ and elevated lactate levels at 4.5 mmol/L, confirming the presence of severe sepsis. Serum creatinine has risen to 3.2 mg/dL from a baseline of 2.1 mg/dL, indicating worsening kidney function. Liver enzymes are elevated, with AST and ALT levels of 85 U/L and 102 U/L, respectively, suggesting hepatic involvement. Blood cultures are pending, but initial findings support the need for broad-spectrum antibiotics, excluding penicillin due to his allergy.
Given these developments, the healthcare team is prompted to reassess their management approach, considering the potential need for more aggressive fluid resuscitation and vasopressor support to stabilize blood pressure. The possibility of mechanical ventilation is discussed due to the patient's declining respiratory status. These findings necessitate swift action to prevent further progression of multi-organ failure, requiring the team to utilize their clinical reasoning skills to prioritize interventions that address both the underlying sepsis and its systemic complications.
Section 2
As the healthcare team moves swiftly to address the patient's critical condition, they decide to initiate more aggressive fluid resuscitation, administering an additional bolus of 500 mL of crystalloid fluids. Despite this, the patient's blood pressure remains dangerously low, with systolic readings hovering around 80 mmHg. Recognizing the need for vasopressor support, the team begins a norepinephrine infusion to help stabilize his hemodynamic status. Concurrently, the decision is made to start the patient on broad-spectrum antibiotics, selecting a regimen of vancomycin and meropenem to cover a wide range of potential pathogens, while awaiting blood culture results to identify the specific causative organism.
As the infusion therapies progress, the patient's respiratory status continues to deteriorate. The team notes that his respiratory rate has increased to 32 breaths per minute, and despite high-flow oxygen therapy, his oxygen saturation struggles to rise above 90%. The decision is made to intubate the patient and initiate mechanical ventilation to ensure adequate oxygenation and reduce the work of breathing. This intervention is critical, given the suspected development of ARDS, as evidenced by the bilateral infiltrates seen on a recent chest X-ray, which further supports this diagnosis.
While these interventions stabilize his respiratory parameters, the patient's renal function raises significant concern. The rise in creatinine, coupled with reduced urine output measured at 15 mL/hr, suggests acute kidney injury secondary to sepsis-induced hypoperfusion. A nephrology consult is requested to assess the need for renal replacement therapy, such as continuous venovenous hemofiltration, to manage the escalating renal failure. These developments highlight the intricate interplay of systems affected by sepsis and underscore the importance of ongoing reassessment and adaptation of the treatment plan to address emerging complications.
Section 3
As the team continues to monitor the patient’s status, new diagnostic results provide additional insight into his condition. The blood culture results return, identifying the presence of Escherichia coli, a gram-negative bacterium, confirming a source of sepsis. This finding prompts a reevaluation of the antibiotic regimen. While the current broad-spectrum coverage with vancomycin and meropenem is appropriate, the team considers the potential for adjusting therapy based on sensitivity patterns to optimize treatment and prevent further complications.
Simultaneously, laboratory results reveal a further decline in renal function. The patient's creatinine level has risen to 3.2 mg/dL from 2.5 mg/dL, and his blood urea nitrogen (BUN) is elevated at 45 mg/dL. These findings, along with persistent oliguria, indicate worsening acute kidney injury. The nephrology consult confirms the need for renal replacement therapy, and preparations are made to initiate continuous venovenous hemofiltration. This intervention aims to manage fluid overload and correct electrolyte imbalances, thereby preventing further systemic complications.
Despite these challenges, there is a slight improvement in the patient’s hemodynamic status following the norepinephrine infusion. His blood pressure stabilizes with a systolic reading now consistently above 90 mmHg, suggesting some responsiveness to vasopressor support. However, the team remains vigilant, aware that the potential for additional complications such as disseminated intravascular coagulation or secondary infections could arise. The focus remains on closely monitoring vital signs, renal function, and laboratory markers, ensuring a proactive approach to any emerging changes in the patient's clinical picture.
Section 4
The following day, the patient's condition presents a new challenge as the team notes the development of respiratory distress. An arterial blood gas (ABG) analysis is performed, revealing a pH of 7.32, partial pressure of carbon dioxide (PaCO2) at 50 mmHg, partial pressure of oxygen (PaO2) at 60 mmHg, and bicarbonate (HCO3-) level at 24 mEq/L. These results indicate respiratory acidosis with hypoxemia, suggesting the onset of acute respiratory distress syndrome (ARDS), a known complication in sepsis patients. The team initiates supplemental oxygen therapy, escalating to non-invasive positive pressure ventilation to improve oxygenation. However, persistent hypoxemia and increased work of breathing prompt consideration for intubation and mechanical ventilation, with the goal of stabilizing respiratory status and preventing further deterioration.
Simultaneously, the patient exhibits signs of potential disseminated intravascular coagulation (DIC). Laboratory tests show a significant decrease in platelet count to 70,000/mm³, elevated D-dimer levels, and prolonged prothrombin time (PT) and activated partial thromboplastin time (aPTT), raising concerns of coagulopathy. These findings necessitate the initiation of blood component therapy, including fresh frozen plasma and platelet transfusions, to correct coagulopathy and prevent bleeding complications.
In the midst of these developments, the multidisciplinary team remains vigilant in reassessing the patient's antibiotic regimen. Given the identification of Escherichia coli and its sensitivity pattern, the decision is made to de-escalate from broad-spectrum antibiotics to a more targeted approach using ceftriaxone. This adjustment aims to effectively manage the infection while reducing the risk of antibiotic-related nephrotoxicity, thus supporting renal recovery. Continuous monitoring of the patient's hemodynamic status, renal function, and coagulation profile remains critical to guiding ongoing therapeutic interventions and anticipating further complications.
Section 5
As the clinical team continues to manage the patient's complex condition, they observe a change in the patient's hemodynamic status. The patient's blood pressure begins to trend downward, with readings dropping to 85/55 mmHg, indicating potential hypotension, despite ongoing fluid resuscitation efforts. Heart rate increases to 120 beats per minute, further suggesting a compensatory response to the declining blood pressure. The patient’s skin appears cool and clammy, and capillary refill time is prolonged, all of which are consistent with signs of shock. These findings prompt the team to initiate vasopressor support with norepinephrine to maintain adequate mean arterial pressure and ensure sufficient tissue perfusion.
In response to these interventions, the patient's blood pressure stabilizes, but the team remains cautious and continues to closely monitor for any signs of further deterioration. Concurrently, repeat ABG analysis reveals a slight improvement in respiratory parameters with a pH of 7.35, PaCO2 reduced to 48 mmHg, and PaO2 increased to 70 mmHg, indicating a positive response to the mechanical ventilation. However, the patient's oxygen saturation remains marginal at 88%, necessitating continued vigilance and potential adjustments in ventilatory settings to optimize gas exchange.
Despite these adjustments, the patient exhibits a new complication: decreased urine output, falling to less than 20 mL/hour. This raises concerns about acute kidney injury secondary to the ongoing sepsis and potential nephrotoxic effects of medications. Serum creatinine levels are elevated at 2.5 mg/dL, confirming renal impairment. These developments prompt the team to revisit the fluid management strategy and consider the need for renal replacement therapy if oliguria persists. As the patient’s condition evolves, the multidisciplinary team remains committed to integrating these clinical findings into a coordinated care plan that prioritizes both stabilization and prevention of further complications.